Skip to main content

Table 7 Antifungal Susceptibility Profile of Candida spp. Isolated from Surgical Wound Patients

From: A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance

Candida spp. Fluconazole Voriconazole Itraconazole
  S R S R S R
C. albicans (n = 54) 48 (88.88%) 6 (11.11%) 54 (100%) 0 (0%) 53 (98.14) 1 (1.85%)
C. glabrata (n = 32) 26 (81.25%) 6 (18.75%) 29 (90.62%) 3 (9.37%) 28 (87.5) 4 (12.5%)
C. tropicalis (n = 12) 11 (91.66%) 1 (8.33%) 11 (91.66%) 1 (8.33%) 10 (83.33%) 2 (16.66%)
C. krusei (n = 13) 0 (0%) 13 (100%) 12 (92.30%) 1 (7.69%) 13 (100%) 0 (0%)
C. parapsilosis (n = 17) 17 (100%) 0 (0%) 17 (100%) 0 (0%) 17 (100) 0 (0%)
  1. S Sensitivity, R Resistance, numbers in parentheses are percentages